
Science
Personalized DNA Vaccine Shows Promise in Treating Glioblastoma
A small phase I study indicates that a bespoke DNA vaccine can increase immune response and extend survival rates for patients with aggressive brain tumors.
Topic
2 stories on glioblastoma, across Science.

A small phase I study indicates that a bespoke DNA vaccine can increase immune response and extend survival rates for patients with aggressive brain tumors.

Research published in Nature indicates that the loss of testosterone suppresses anti-tumor immunity and triggers the HPA axis to drive glioblastoma progression in males.